Recombinant Tissue Plasminogen Activator (rtPA) for the Treatment of Hepatic Veno-Occlusive Disease (VOD)

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1701654
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hepatic Veno-Occlusive Disease: Report of a Case

Jornal de Pediatria
Child HealthPediatricsPerinatology
1997English

Recent Developments With Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome

Expert Opinion on Orphan Drugs
ToxicologyPharmaceuticsPharmacologyHealth Policy
2019English

Compatibility of Recombinant Tissue Plasminogen Activator (rtPA) and Aflibercept or Ranibizumab Coapplied for Neovascular Age-Related Macular Degeneration With Submacular Haemorrhage

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2015English

Phase I Study of Intraventricular Recombinant Tissue Plasminogen Activator for Treatment of Posthaemorrhagic Hydrocephalus.

Archives of Disease in Childhood: Fetal and Neonatal Edition
PediatricsGynecologyPerinatologyObstetricsMedicineChild Health
1996English

Low Molecular Weight Heparin for the Prevention of Hepatic Veno-Occlusive Disease (VOD) After Hematopoietic Stem Cell Transplantation: A Prospective Phase II Study

Bone Marrow Transplantation
TransplantationHematology
2003English

Expanding Recombinant Tissue Plasminogen Activator Time Window Is Premature

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2009English

Pulmonary Veno-Occlusive Disease

Acta Medica Scandinavica
2009English

Defibrotide – A New Treatment Approach for Severe Veno-Occlusive Disease

European Oncology and Haematology
OncologyHematology
2015English

Pulmonary Veno-Occlusive Disease

The Lancet
Medicine
1979English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy